Resveratrol Inhibits the Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (sars‐cov‐2) in Cultured Vero Cells
Minghui Yang,Jinli Wei,Ting Huang,Luping Lei,Chenguang Shen,Jinzhi Lai,Min Yang,Lei Liu,Yang,Guoshi Liu,Yingxia Liu
DOI: https://doi.org/10.1002/ptr.6916
2020-01-01
Abstract:Phytotherapy ResearchVolume 35, Issue 3 p. 1127-1129 LETTER TO THE EDITOR Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells Minghui Yang, Minghui Yang orcid.org/0000-0001-9617-3245 Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaSearch for more papers by this authorJinli Wei, Jinli Wei Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorTing Huang, Ting Huang Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorLuping Lei, Luping Lei Beijing TongRen Hospital, Capital Medical University, Beijing, ChinaSearch for more papers by this authorChenguang Shen, Chenguang Shen Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaSearch for more papers by this authorJinzhi Lai, Jinzhi Lai Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorMin Yang, Min Yang Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorLei Liu, Lei Liu Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorYang Yang, Yang Yang Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorGuoshi Liu, Guoshi Liu College of Animal Science and Technology, China Agricultural University, Beijing, ChinaSearch for more papers by this authorYingxia Liu, Corresponding Author Yingxia Liu [email protected] Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China Correspondence Yingxia Liu, Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. Email: [email protected]Search for more papers by this author Minghui Yang, Minghui Yang orcid.org/0000-0001-9617-3245 Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaSearch for more papers by this authorJinli Wei, Jinli Wei Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorTing Huang, Ting Huang Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorLuping Lei, Luping Lei Beijing TongRen Hospital, Capital Medical University, Beijing, ChinaSearch for more papers by this authorChenguang Shen, Chenguang Shen Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaSearch for more papers by this authorJinzhi Lai, Jinzhi Lai Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorMin Yang, Min Yang Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorLei Liu, Lei Liu Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorYang Yang, Yang Yang Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSearch for more papers by this authorGuoshi Liu, Guoshi Liu College of Animal Science and Technology, China Agricultural University, Beijing, ChinaSearch for more papers by this authorYingxia Liu, Corresponding Author Yingxia Liu [email protected] Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China Correspondence Yingxia Liu, Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. Email: [email protected]Search for more papers by this author First published: 22 November 2020 https://doi.org/10.1002/ptr.6916Citations: 71 Minghui Yang and Jinli Wei contributed equally to this work. Yang Yang, Guoshi Liu and Yingxia Liu contributed equally to this work. Funding information: China Postdoctoral Science Foundation, Grant/Award Number: 2019M660836; Shenzhen Natural Science Foundation, Grant/Award Number: JCYJ20190809152415652; Shenzhen Science and Technology Research and Development Project, Grant/Award Number: 202002073000001; The National Science and Technology Major Project, Grant/Award Number: 2018ZX10711001 2017ZX10103011 2018ZX09711003 2020YFC0841700 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., … Piccirilli, G. (2010). Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Research, 70, 9003–9011. 10.1158/0008-5472.CAN-10-2364 CASPubMedWeb of Science®Google Scholar Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., … Wang, C. (2020). A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. The New England Journal of Medicine, 382(19), 1787–1799. 10.1056/NEJMoa2001282 PubMedWeb of Science®Google Scholar Côté, C. D., Rasmussen, B. A., Duca, F. A., Zadeh-Tahmasebi, M., Baur, J. A., Daljeet, M., … Lam, T. K. (2015). Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. Nature Medicine, 21, 498–505. 10.1038/nm.3821 CASPubMedWeb of Science®Google Scholar Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … Gu, X. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395, 497–506. 10.1016/S0140-6736(20)30183-5 CASPubMedWeb of Science®Google Scholar Li, Y., Wang, J., Zhang, Z., Yi, J., He, C., Wang, F., … He, P. (2016). Resveratrol compares with melatonin in improving in vitro porcine oocyte maturation under heat stress. Journal of Animal Science and Biotechnology, 7, 33. 10.1186/s40104-016-0093-9 PubMedWeb of Science®Google Scholar Lin, S. C., Ho, C. T., Chuo, W. H., Li, S., Wang, T. T., & Lin, C. C. (2017). Effective inhibition of MERS-CoV infection by resveratrol. BMC Infectious Diseases, 17, 144. 10.1186/s12879-017-2253-8 PubMedWeb of Science®Google Scholar Mohd, A., Zainal, N., Tan, K. K., & Sazaly, A. B. (2019). Resveratrol affects Zika virus replication in vitro. Scientific Reports, 9(1), 1–11. 10.1038/s41598-019-50674-3 CASPubMedWeb of Science®Google Scholar Paemanee, A., Hitakarun, A., Roytrakul, S., & Duncan, R. S. (2018). Screening of melatonin, α-tocopherol, folic acid, acetyl-L-carnitine and resveratrol for anti-dengue 2 virus activity. BMC Research Notes, 11(1), 1–7. 10.1186/s13104-018-3417-3 PubMedGoogle Scholar Wahedi, H. M., Ahmad, S., & Abbasi, S. W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure & Dynamics, 12, 1–16. 10.1080/07391102.2020.1762743 Web of Science®Google Scholar Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., … Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. 10.1038/s41422-020-0282-0 CASPubMedWeb of Science®Google Scholar Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., … Wang, C. (2020). Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial. Lancet, 395(10236), 1569–1578. 10.1016/S0140-6736(20)31022-9 CASPubMedWeb of Science®Google Scholar WHO. (2020). Coronavirus disease 2019 (COVID-19) Situation Report. Google Scholar Citing Literature Volume35, Issue3March 2021Pages 1127-1129 This article also appears in:Phytocompounds and COVID-19: two years of knowledge ReferencesRelatedInformation